1. Home
  2. SGHT vs VALU Comparison

SGHT vs VALU Comparison

Compare SGHT & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$8.51

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Logo Value Line Inc.

VALU

Value Line Inc.

HOLD

Current Price

$37.80

Market Cap

341.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
VALU
Founded
2011
1931
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
309.6M
341.6M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
SGHT
VALU
Price
$8.51
$37.80
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$9.08
N/A
AVG Volume (30 Days)
263.8K
2.5K
Earning Date
05-06-2026
03-16-2026
Dividend Yield
N/A
3.72%
EPS Growth
28.16
4.55
EPS
N/A
2.30
Revenue
$77,363,000.00
$36,257,000.00
Revenue This Year
$11.67
N/A
Revenue Next Year
$10.39
N/A
P/E Ratio
N/A
$16.01
Revenue Growth
N/A
1.08
52 Week Low
$3.19
$32.00
52 Week High
$9.24
$41.18

Technical Indicators

Market Signals
Indicator
SGHT
VALU
Relative Strength Index (RSI) 73.02 48.67
Support Level $8.00 $36.26
Resistance Level $8.80 $38.04
Average True Range (ATR) 0.37 1.28
MACD -0.04 0.07
Stochastic Oscillator 59.84 23.10

Price Performance

Historical Comparison
SGHT
VALU

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and makes available copyright data, including a ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets its products under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing, and The Most Trusted Name in Investment Research. Its only operating segment is Publishing.

Share on Social Networks: